2017 has been a remarkable year for the clinical industry
in many ways, driven by many methods, regulations, and technology.There are advancements made by the FDA by laying out the foundation for digital health
, patient centricity
is evolving to include Quality management systems are starting to leverage predictive modeling and adaptive governance and oversight models.In 2018 we are likely to see growth in virtual trials
and site-centric approaches towards clinical trials execution and other new concepts involving patients as drivers for study design.